Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

2.
4.

Baicalin, an inhibitor of HIV-1 production in vitro.

Kitamura K, Honda M, Yoshizaki H, Yamamoto S, Nakane H, Fukushima M, Ono K, Tokunaga T.

Antiviral Res. 1998 Feb;37(2):131-40.

PMID:
9588845
5.
6.

A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.

Wang HG, Williams RE, Lin PF.

Curr Pharm Des. 2004;10(15):1785-93. Review.

PMID:
15180540
7.

Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.

Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C.

Mol Pharmacol. 2000 Nov;58(5):1100-8.

9.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.

Virology. 2005 Sep 1;339(2):213-25.

10.

Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.

Vermeire K, Schols D.

Expert Opin Investig Drugs. 2005 Oct;14(10):1199-212. Review.

PMID:
16185162
11.

Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.

Szabó J, Cervenák L, Tóth FD, Prohászka Z, Horváth L, Kerekes K, Beck Z, Bácsi A, Erdei A, Peerschke EI, Füst G, Ghebrehiwet B.

Clin Immunol. 2001 May;99(2):222-31.

PMID:
11318594
13.

Human immunodeficiency virus type 1 inhibitory activity of Mentha longifolia.

Amzazi S, Ghoulami S, Bakri Y, Il Idrissi A, Fkih-Tétouani S, Benjouad A.

Therapie. 2003 Nov-Dec;58(6):531-4.

PMID:
15058498
14.

Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.

de Soultrait VR, Desjobert C, Tarrago-Litvak L.

Curr Med Chem. 2003 Sep;10(18):1765-78. Review.

PMID:
12871103
15.

The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.

Au TK, Collins RA, Lam TL, Ng TB, Fong WP, Wan DC.

FEBS Lett. 2000 Apr 14;471(2-3):169-72.

16.

A search for anti-viral properties in Panamanian medicinal plants. The effects on HIV and its essential enzymes.

Matsuse IT, Lim YA, Hattori M, Correa M, Gupta MP.

J Ethnopharmacol. 1999 Jan;64(1):15-22.

PMID:
10075118
17.

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.

Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D.

AIDS. 2004 Nov 5;18(16):2115-25.

PMID:
15577644
18.
19.

RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses.

Fujiwara M, Ashida N, Okamoto M, Mizuta T, Ide T, Hanasaki Y, Katsuura K, Sawada H, Shigeta S, Konno K, Yokota T, Baba M.

Antiviral Res. 1998 May;38(2):141-9.

PMID:
9707376
20.

Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha.

Takeda-Hirokawa N, Neoh LP, Akimoto H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Hirose S, Murakami T, Yamamoto N, Mimura T, Kaneko Y.

Microbiol Immunol. 1997;41(9):741-5.

Supplemental Content

Support Center